Drug intelligence / Profile preview

autologous alveolar bone marrow mesenchymal stem cells + fibrin glue + collagen fleece

Development stage
Unknown
Lead developer
Aristotle University of Thessaloniki
Modality
Stem Cell Therapies → Cell Therapies
Administration
Implant
01

Overview

BM-MSCs + fibrin glue + collagen fleece is an autologous, tissue-engineered regenerative biocomplex developed by the Aristotle University of Thessaloniki for the treatment of chronic periodontitis. The product consists of autologous alveolar bone marrow-derived mesenchymal stem cells (BM-MSCs) that are expanded in clean-room facilities under animal-reagent-free conditions. These cells are then seeded onto a collagen fleece scaffold enriched with autologous fibrin glue. The biocomplex is surgically implanted into infrabony periodontal defects, where it acts to regenerate the complex periodontal apparatus, including alveolar bone, cementum, and the periodontal ligament. It has been evaluated in the Phase I/II 'PerioRegen' clinical trial (NCT02449005).

Other names
BM-MSCs + fibrin glue + collagen fleeceaBM-MSCs + fibrin glue + collagen fleeceautologous alveolar bone marrow mesenchymal stem cellstissue-engineered regenerative biocomplex

Beyond the preview

Go deeper on autologous alveolar bone marrow mesenchymal stem cells + fibrin glue + collagen fleece.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous alveolar bone marrow mesenchymal stem cells + fibrin glue + collagen fleece.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call